Cabel - The Forbes article is great to get more people thinking about epigenetics but didn't have the meat we need to promote medically changing reactions. All exposure is good right now though. 

The Daily Mail article certainly sets us up for a win. 6 million people on statins currently in the UK. If our trial results show a 30% RRR in combination with the current standard of care, statins, then this could be extremely good for us.

I'm not a surfer but it looks like this wave is building now and we will have results out before it crests allowing us to ride it for quite some time.

tada